Package 50242-210-90
Brand: gavreto
Generic: pralsetinibPackage Facts
Identity
Package NDC
50242-210-90
Digits Only
5024221090
Product NDC
50242-210
Description
1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE
Marketing
Marketing Status
Brand
gavreto
Generic
pralsetinib
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "202f12fc-4f57-4e69-bf7b-73d7c1d1ed0c", "openfda": {"nui": ["N0000175605", "N0000193947"], "unii": ["1WPE73O1WV"], "rxcui": ["2394941", "2394947"], "spl_set_id": ["59984249-e3ff-4f97-8d7a-c1a905d604a8"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Rearranged during Transfection (RET) Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE", "package_ndc": "50242-210-60", "marketing_end_date": "20260930", "marketing_start_date": "20210701"}, {"sample": true, "description": "1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE", "package_ndc": "50242-210-83", "marketing_end_date": "20260930", "marketing_start_date": "20210701"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE", "package_ndc": "50242-210-90", "marketing_end_date": "20260930", "marketing_start_date": "20210701"}], "brand_name": "Gavreto", "product_id": "50242-210_202f12fc-4f57-4e69-bf7b-73d7c1d1ed0c", "dosage_form": "CAPSULE", "pharm_class": ["Kinase Inhibitor [EPC]", "Rearranged during Transfection (RET) Inhibitors [MoA]"], "product_ndc": "50242-210", "generic_name": "Pralsetinib", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gavreto", "active_ingredients": [{"name": "PRALSETINIB", "strength": "100 mg/1"}], "application_number": "NDA213721", "marketing_category": "NDA", "marketing_end_date": "20260930", "marketing_start_date": "20210701"}